Dyne Therapeutics Inc (DYN)
23.87
+0.22
(+0.93%)
USD |
NASDAQ |
Apr 19, 16:00
23.87
0.00 (0.00%)
After-Hours: 16:58
Dyne Therapeutics Total Assets (Quarterly): 165.08M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 165.08M |
| September 30, 2023 | 205.24M |
| June 30, 2023 | 251.42M |
| March 31, 2023 | 288.64M |
| December 31, 2022 | 306.32M |
| September 30, 2022 | 299.68M |
| June 30, 2022 | 340.03M |
| March 31, 2022 | 387.76M |
| Date | Value |
|---|---|
| December 31, 2021 | 425.66M |
| September 30, 2021 | 466.88M |
| June 30, 2021 | 467.15M |
| March 31, 2021 | 491.71M |
| December 31, 2020 | 353.33M |
| September 30, 2020 | 381.47M |
| June 30, 2020 | 146.77M |
| December 31, 2019 | 16.44M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
16.44M
Minimum
Dec 2019
491.71M
Maximum
Mar 2021
312.10M
Average
323.18M
Median
Total Assets (Quarterly) Benchmarks
| Rocket Pharmaceuticals Inc | 566.34M |
| Solid Biosciences Inc | 164.94M |
| Avidity Biosciences Inc | 628.56M |
| Sana Biotechnology Inc | 565.30M |
| Tenaya Therapeutics Inc | 170.52M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 73.79M |
| Shareholders Equity (Quarterly) | 91.29M |